Q

Qu Biologics Inc.

18 employees

Qu Biologics develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
arthritis
pharmaceuticals
cancer
autoimmune diseases
immunotherapies
research
ulcerative colitis
biotechnology
IBD
innate immunity
clinical trials
Health Care
inflammation
COVID
Site Specific Immunomodulators
investigational drug
Crohn's disease
autoimmune disorders
Medical
inflammatory bowel disease
biotech
biologics

Date founded

2007

Funding rounds raised

Q

Qu Biologics Inc. raised undisclosed on November 2, 2020

Investors: Harmonix

Q

Qu Biologics Inc. raised undisclosed on August 1, 2019

Investors: ACA Inc.

FAQ